Allarity Therapeutics, Inc. (ALLR) vs PAVmed Inc. (PAVM)
A side-by-side comparison of Allarity Therapeutics, Inc. and PAVmed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$0.99HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
PAVM
PAVmed Inc.
$2.71HealthcareDelayed quote: Oct 6, 2026, 1:36 PM EDT
Total return — ALLR vs PAVM
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)PAVM -99.8% (-71.3%/yr)PAVM compounded faster over this window
Log scale — wide-divergence pair
ALLR PAVM
ALLR vs PAVM: by the numbers
- •PAVM is the larger company ($17M vs $16M market cap).
- •Both run net losses; ALLR's is the smaller (-3575.07% vs -10794.64% net margin).
Metrics side by side
Valuation
| Metric | ALLR | PAVM |
|---|---|---|
| P/S ratio | 45.54 | 154.16 |
| P/B ratio | 4.44 | 0.55 |
Profitability
| Metric | ALLR | PAVM |
|---|---|---|
| Gross margin | 107.54% | -354.93% |
| Operating margin | -3939.06% | -30712.68% |
| Net margin | -3575.07% | -10794.64% |
| ROE | -348.81% | -34.50% |
| ROIC | -41.81% | -73.92% |
Growth (annualized)
| Metric | ALLR | PAVM |
|---|---|---|
| Total return CAGR (5Y) | N/A | -76.55% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.